BYDUREON (exenatide extended release for injectable suspension) just received FDA approval. Special thanks to all of the participants in these clinical trials as well as every PMG site!
BYDUREON is the first and only treatment for adults with Type 2 Diabetes that delivers continuous glycemic control in a single weekly dose. Learn more about BYDUREON HERE...
Subscribe to:
Post Comments
(
Atom
)
No comments :
Post a Comment